SEPTInvestingStart Free

NXTC 10-Q: SEC filing

NextCure

Filed with the SEC on · accession 0001104659-26-125220

NXTC filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -4.6% by the first close after the filing.

Summary of the filing

NextCure filed its Q3 2026 10-Q, reporting a net loss of $0.08 per share and disclosing a subsequent merger agreement with Avere Therapeutics dated November 6, 2026.

For details, click here →How to read a 10-Q →

Key details

Net loss per share$0
FilerNextCure, Inc.
Merger counterpartyAvere Therapeutics, Inc.

How NXTC stock reacted

Close before

$6.27

Nov 9, 2026

First close after

-4.63%

$5.98

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for NXTC, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for NXTC?

Click here

Frequently asked questions

What did NXTC file with the SEC on Nov 10, 2026?

NXTC filed a 10-Q (SEC filing). NextCure filed its Q3 2026 10-Q, reporting a net loss of $0.08 per share and disclosing a subsequent merger agreement with Avere Therapeutics dated November 6, 2026.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did NXTC stock react to this filing?

NXTC closed at $6.27 before the filing and $5.98 on Nov 10, 2026 (-4.63%).

Other NXTC SEC filings

Get alerts when NXTC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
NXTC overviewNXTC analysisNXTC newsLatest SEC filings